First-dose idarubicin cardiomyopathy: a case of new heart failure after induction chemotherapy for acute myeloid leukaemia

Anthracyclines are an effective chemotherapy agent. However, very few cases of idarubicin-induced cardiomyopathy exist. Herein, we describe a case of first-dose idarubicin-related acute heart failure in a woman with a history of myelodysplastic syndrome converted to acute myeloid leukaemia.

Saved in:
Bibliographic Details
Published in:BMJ Case Rep
Main Authors: Ahmed, Zarir, Davaro, Elizabeth, Batanian, Jacqueline, Verma, Nilesh
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2019
Subjects:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536188/
https://ncbi.nlm.nih.gov/pubmed/31101747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-228149
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items